More generally, mitochondrion dysfunctions, either promoted by mutation in FH, isocitrate dehydrogenase (IDH), and succinate dehydrogenase (SDH) (seldom reported in breast cancer) or by other mechanism (for a comprehensive review see [73]), are described as possibly contributing to initiation and progression of cancer. Here, IDH2 is linked to breast carcinoma.